Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The objective of this study is to assess the efficacy and safety of SOTB07 in asthma patients by observing changes FEV1 (% predicted) as the primary efficacy endpoint after oral administration of SOTB07 200mg, 400mg, placebo for 12 weeks.
Epistemonikos ID: c0f0fa85b8ec70a2d328ff88adbadd27e2f38cf2
First added on: May 11, 2024